Yun Zhong
Stock Analyst at Wedbush
(0.08)
# 4,377
Out of 4,429 analysts
407
Total ratings
37.6%
Success rate
-10%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yun Zhong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MLTX MoonLake Immunotherapeutics | Maintained: Buy | $34 | $22.16 | +53.43% | 21 | Jun 22, 2026 | |
| SGMT Sagimet Biosciences | Maintained: Buy | $28 | $7.10 | +294.37% | 11 | Jun 22, 2026 | |
| IRD Opus Genetics | Maintained: Buy | $10 | $4.08 | +145.10% | 7 | Jun 17, 2026 | |
| ASND Ascendis Pharma | Maintained: Buy | $273 | $228.00 | +19.74% | 28 | Jun 15, 2026 | |
| RZLT Rezolute | Rated: Buy | $5 → $6 | $5.15 | +16.50% | 23 | Jun 3, 2026 | |
| MNKD MannKind | Maintained: Buy | $8 | $3.89 | +105.66% | 24 | Jun 1, 2026 | |
| KLRS Kalaris Therapeutics | Maintained: Buy | $17 | $4.40 | +286.36% | 2 | Jun 1, 2026 | |
| WVE Wave Life Sciences | Maintained: Buy | $15 | $6.17 | +143.11% | 20 | May 27, 2026 | |
| BMRN BioMarin Pharmaceutical | Rated: Buy | $94 | $55.90 | +68.16% | 16 | May 21, 2026 | |
| KROS Keros Therapeutics | Maintained: Hold | $16 | $10.98 | +45.72% | 15 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $3.72 | +115.05% | 23 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $17.65 | +98.30% | 29 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $3.46 | +362.43% | 21 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $4.20 | +90.48% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $112 → $118 | $115.03 | +2.58% | 28 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $8 | $5.72 | +39.86% | 24 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $28 | $2.54 | n/a | 15 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.53 | n/a | 14 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $38 | $44.39 | n/a | 19 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $30.34 | n/a | 13 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $9.95 | n/a | 13 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $0.325 | n/a | 9 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.82 | n/a | 7 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $87.37 | n/a | 9 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.37 | n/a | 3 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $13.89 | n/a | 2 | Feb 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $24.05 | n/a | 1 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.28 | n/a | 3 | Jun 28, 2018 |
MoonLake Immunotherapeutics
Jun 22, 2026
Maintained: Buy
Price Target: $34
Current: $22.16
Upside: +53.43%
Sagimet Biosciences
Jun 22, 2026
Maintained: Buy
Price Target: $28
Current: $7.10
Upside: +294.37%
Opus Genetics
Jun 17, 2026
Maintained: Buy
Price Target: $10
Current: $4.08
Upside: +145.10%
Ascendis Pharma
Jun 15, 2026
Maintained: Buy
Price Target: $273
Current: $228.00
Upside: +19.74%
Rezolute
Jun 3, 2026
Rated: Buy
Price Target: $5 → $6
Current: $5.15
Upside: +16.50%
MannKind
Jun 1, 2026
Maintained: Buy
Price Target: $8
Current: $3.89
Upside: +105.66%
Kalaris Therapeutics
Jun 1, 2026
Maintained: Buy
Price Target: $17
Current: $4.40
Upside: +286.36%
Wave Life Sciences
May 27, 2026
Maintained: Buy
Price Target: $15
Current: $6.17
Upside: +143.11%
BioMarin Pharmaceutical
May 21, 2026
Rated: Buy
Price Target: $94
Current: $55.90
Upside: +68.16%
Keros Therapeutics
May 19, 2026
Maintained: Hold
Price Target: $16
Current: $10.98
Upside: +45.72%
May 18, 2026
Maintained: Buy
Price Target: $8
Current: $3.72
Upside: +115.05%
May 15, 2026
Maintained: Buy
Price Target: $35
Current: $17.65
Upside: +98.30%
May 8, 2026
Reiterated: Buy
Price Target: $16
Current: $3.46
Upside: +362.43%
May 8, 2026
Maintained: Buy
Price Target: $8
Current: $4.20
Upside: +90.48%
May 6, 2026
Rated: Buy
Price Target: $112 → $118
Current: $115.03
Upside: +2.58%
Apr 21, 2026
Downgraded: Hold
Price Target: $8
Current: $5.72
Upside: +39.86%
Mar 30, 2023
Rated: Buy
Price Target: $28
Current: $2.54
Upside: n/a
Mar 30, 2023
Maintained: Hold
Price Target: n/a
Current: $6.53
Upside: n/a
Mar 28, 2023
Rated: Buy
Price Target: $38
Current: $44.39
Upside: n/a
Mar 23, 2023
Reiterated: Buy
Price Target: $4
Current: $30.34
Upside: n/a
Mar 21, 2023
Maintained: Buy
Price Target: $8
Current: $9.95
Upside: n/a
Mar 21, 2023
Maintained: Buy
Price Target: $4
Current: $0.325
Upside: n/a
Mar 21, 2023
Reiterated: Hold
Price Target: n/a
Current: $5.82
Upside: n/a
Jan 26, 2023
Downgraded: Hold
Price Target: n/a
Current: $87.37
Upside: n/a
May 12, 2020
Reiterated: Buy
Price Target: $10
Current: $1.37
Upside: n/a
Feb 4, 2020
Reiterated: Buy
Price Target: $14
Current: $13.89
Upside: n/a
Nov 12, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $24.05
Upside: n/a
Jun 28, 2018
Downgraded: Hold
Price Target: n/a
Current: $14.28
Upside: n/a